Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Natriuretic Peptide, Brain | 37 | 2021 | 1717 | 3.400 |
Why?
|
Heart Failure | 59 | 2021 | 11847 | 2.530 |
Why?
|
Peptide Fragments | 32 | 2021 | 5125 | 2.320 |
Why?
|
Troponin T | 10 | 2020 | 774 | 1.580 |
Why?
|
Stroke Volume | 22 | 2021 | 5523 | 1.010 |
Why?
|
Ventricular Remodeling | 10 | 2019 | 1261 | 0.960 |
Why?
|
Endothelin-1 | 4 | 2018 | 302 | 0.800 |
Why?
|
Adrenergic beta-Antagonists | 7 | 2019 | 1259 | 0.790 |
Why?
|
Dyspnea | 6 | 2021 | 1352 | 0.750 |
Why?
|
Heart Failure, Systolic | 3 | 2017 | 136 | 0.720 |
Why?
|
Receptors, Cell Surface | 7 | 2015 | 2825 | 0.680 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 6 | 2020 | 206 | 0.670 |
Why?
|
Troponin I | 7 | 2020 | 638 | 0.650 |
Why?
|
Ventricular Function, Left | 11 | 2020 | 3880 | 0.620 |
Why?
|
Ventricular Dysfunction, Left | 10 | 2020 | 2128 | 0.580 |
Why?
|
Acute Coronary Syndrome | 5 | 2018 | 2365 | 0.540 |
Why?
|
Prognosis | 37 | 2020 | 29658 | 0.540 |
Why?
|
Cardiovascular Agents | 4 | 2019 | 867 | 0.540 |
Why?
|
Myocardial Infarction | 6 | 2020 | 11891 | 0.540 |
Why?
|
Angiography | 3 | 2018 | 1605 | 0.500 |
Why?
|
Cachexia | 1 | 2016 | 198 | 0.490 |
Why?
|
Oxygen Consumption | 2 | 2017 | 1843 | 0.450 |
Why?
|
Echocardiography | 9 | 2020 | 4981 | 0.420 |
Why?
|
Natriuretic Peptides | 1 | 2014 | 156 | 0.420 |
Why?
|
Growth Differentiation Factor 15 | 1 | 2014 | 196 | 0.400 |
Why?
|
Patient Participation | 1 | 2021 | 1439 | 0.390 |
Why?
|
Myocardium | 4 | 2017 | 4700 | 0.380 |
Why?
|
Outpatients | 4 | 2016 | 1607 | 0.380 |
Why?
|
Predictive Value of Tests | 21 | 2020 | 15289 | 0.370 |
Why?
|
Coronary Artery Disease | 8 | 2020 | 6659 | 0.370 |
Why?
|
Coronary Circulation | 1 | 2017 | 1577 | 0.370 |
Why?
|
Echocardiography, Doppler, Pulsed | 1 | 2010 | 69 | 0.350 |
Why?
|
Protein Precursors | 4 | 2016 | 1134 | 0.350 |
Why?
|
Galectin 3 | 4 | 2015 | 240 | 0.330 |
Why?
|
Risk Assessment | 17 | 2019 | 24123 | 0.330 |
Why?
|
Heart Rate | 2 | 2019 | 4179 | 0.320 |
Why?
|
Chronic Disease | 15 | 2018 | 9287 | 0.320 |
Why?
|
Coronary Stenosis | 4 | 2020 | 820 | 0.320 |
Why?
|
Coronary Angiography | 7 | 2019 | 4563 | 0.310 |
Why?
|
Quality of Life | 4 | 2021 | 13308 | 0.300 |
Why?
|
Disease Management | 2 | 2018 | 2514 | 0.290 |
Why?
|
Guideline Adherence | 1 | 2017 | 2283 | 0.280 |
Why?
|
Aged | 56 | 2024 | 169152 | 0.270 |
Why?
|
Middle Aged | 53 | 2024 | 220352 | 0.270 |
Why?
|
Prospective Studies | 25 | 2020 | 54303 | 0.260 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2010 | 866 | 0.260 |
Why?
|
Proteomics | 4 | 2020 | 3817 | 0.260 |
Why?
|
Patient Readmission | 3 | 2018 | 3323 | 0.260 |
Why?
|
Oxygen | 1 | 2017 | 4193 | 0.250 |
Why?
|
Emergency Service, Hospital | 5 | 2021 | 7818 | 0.240 |
Why?
|
Follow-Up Studies | 21 | 2020 | 39261 | 0.240 |
Why?
|
Heart Failure, Diastolic | 2 | 2016 | 76 | 0.240 |
Why?
|
Male | 62 | 2024 | 359744 | 0.230 |
Why?
|
Atrial Natriuretic Factor | 3 | 2015 | 350 | 0.230 |
Why?
|
Electrocardiography | 1 | 2017 | 6414 | 0.220 |
Why?
|
Humans | 84 | 2024 | 760621 | 0.220 |
Why?
|
Acute Disease | 8 | 2021 | 7269 | 0.220 |
Why?
|
Female | 64 | 2024 | 391270 | 0.220 |
Why?
|
Cause of Death | 5 | 2019 | 3725 | 0.200 |
Why?
|
Tetrazoles | 2 | 2019 | 905 | 0.200 |
Why?
|
Cardiovascular Diseases | 8 | 2019 | 15757 | 0.190 |
Why?
|
Electric Countershock | 1 | 2024 | 537 | 0.190 |
Why?
|
ROC Curve | 6 | 2020 | 3568 | 0.190 |
Why?
|
Disease Progression | 11 | 2018 | 13502 | 0.190 |
Why?
|
Medicare | 1 | 2019 | 6786 | 0.180 |
Why?
|
Habits | 1 | 2021 | 146 | 0.170 |
Why?
|
Neprilysin | 2 | 2020 | 472 | 0.170 |
Why?
|
Renal Insufficiency | 2 | 2016 | 820 | 0.170 |
Why?
|
Time Factors | 14 | 2020 | 40165 | 0.170 |
Why?
|
Hyperlipoproteinemias | 1 | 2019 | 20 | 0.170 |
Why?
|
Patient Selection | 2 | 2016 | 4283 | 0.160 |
Why?
|
Angiotensin Receptor Antagonists | 3 | 2020 | 1031 | 0.160 |
Why?
|
Echocardiography, Transesophageal | 1 | 2024 | 1108 | 0.150 |
Why?
|
Sodium Potassium Chloride Symporter Inhibitors | 2 | 2016 | 150 | 0.150 |
Why?
|
Treatment Outcome | 17 | 2019 | 65017 | 0.150 |
Why?
|
Amyloidosis | 1 | 2024 | 817 | 0.150 |
Why?
|
Aged, 80 and over | 15 | 2020 | 58995 | 0.140 |
Why?
|
Lipocalins | 2 | 2015 | 161 | 0.140 |
Why?
|
Systole | 2 | 2016 | 947 | 0.140 |
Why?
|
Tissue Survival | 1 | 2017 | 119 | 0.140 |
Why?
|
Nutrition Disorders | 1 | 2017 | 205 | 0.140 |
Why?
|
Apolipoproteins | 1 | 2019 | 320 | 0.140 |
Why?
|
Acute Kidney Injury | 3 | 2020 | 1941 | 0.140 |
Why?
|
Peripheral Arterial Disease | 2 | 2018 | 1306 | 0.140 |
Why?
|
Nutritional Sciences | 1 | 2017 | 143 | 0.130 |
Why?
|
Neurotensin | 1 | 2016 | 57 | 0.130 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 4 | 2016 | 1523 | 0.130 |
Why?
|
Adrenomedullin | 2 | 2015 | 85 | 0.130 |
Why?
|
Risk Factors | 16 | 2019 | 74359 | 0.130 |
Why?
|
Receptors, Interleukin-1 | 2 | 2014 | 261 | 0.130 |
Why?
|
Cystatin C | 2 | 2014 | 270 | 0.130 |
Why?
|
Catheterization | 2 | 2018 | 1432 | 0.130 |
Why?
|
Glomerular Filtration Rate | 3 | 2018 | 2180 | 0.130 |
Why?
|
Catheters | 1 | 2018 | 425 | 0.130 |
Why?
|
Necrosis | 2 | 2017 | 1612 | 0.130 |
Why?
|
Blood Proteins | 2 | 2018 | 1173 | 0.120 |
Why?
|
Heart | 2 | 2020 | 4393 | 0.120 |
Why?
|
Biphenyl Compounds | 2 | 2019 | 992 | 0.120 |
Why?
|
Acetylglucosaminidase | 1 | 2014 | 67 | 0.120 |
Why?
|
Heart Ventricles | 3 | 2017 | 3811 | 0.120 |
Why?
|
Severity of Illness Index | 7 | 2019 | 15840 | 0.120 |
Why?
|
Catheterization, Peripheral | 1 | 2018 | 345 | 0.120 |
Why?
|
Proportional Hazards Models | 6 | 2019 | 12531 | 0.110 |
Why?
|
Troponin | 1 | 2018 | 516 | 0.110 |
Why?
|
Calcitonin | 1 | 2015 | 330 | 0.110 |
Why?
|
Immunoassay | 1 | 2017 | 746 | 0.110 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2017 | 10827 | 0.110 |
Why?
|
Vietnam | 1 | 2014 | 411 | 0.110 |
Why?
|
Limit of Detection | 1 | 2014 | 280 | 0.110 |
Why?
|
Patient Care | 1 | 2018 | 624 | 0.110 |
Why?
|
Behavior Therapy | 1 | 2018 | 868 | 0.110 |
Why?
|
Pneumonia, Bacterial | 1 | 2015 | 319 | 0.100 |
Why?
|
Survival Rate | 6 | 2017 | 12808 | 0.100 |
Why?
|
Risk Reduction Behavior | 1 | 2018 | 1109 | 0.100 |
Why?
|
Dizziness | 1 | 2014 | 257 | 0.100 |
Why?
|
Fibrinogen | 1 | 2014 | 886 | 0.090 |
Why?
|
Saphenous Vein | 1 | 2014 | 537 | 0.090 |
Why?
|
Ischemic Attack, Transient | 1 | 2016 | 901 | 0.090 |
Why?
|
Primary Prevention | 1 | 2018 | 1207 | 0.090 |
Why?
|
Graft Occlusion, Vascular | 1 | 2014 | 560 | 0.090 |
Why?
|
Age Factors | 4 | 2018 | 18416 | 0.090 |
Why?
|
Sex Factors | 4 | 2020 | 10547 | 0.090 |
Why?
|
Body Mass Index | 2 | 2019 | 12914 | 0.090 |
Why?
|
Internationality | 1 | 2015 | 1004 | 0.090 |
Why?
|
Feasibility Studies | 1 | 2021 | 5201 | 0.090 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2015 | 1135 | 0.080 |
Why?
|
Terminology as Topic | 1 | 2017 | 1535 | 0.080 |
Why?
|
Myocardial Contraction | 1 | 2014 | 1516 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 6 | 2016 | 6544 | 0.080 |
Why?
|
Kidney Function Tests | 3 | 2016 | 681 | 0.080 |
Why?
|
United States | 8 | 2021 | 72461 | 0.080 |
Why?
|
Patient Compliance | 1 | 2019 | 2688 | 0.080 |
Why?
|
Randomized Controlled Trials as Topic | 6 | 2016 | 10344 | 0.080 |
Why?
|
Diagnosis, Differential | 3 | 2017 | 12965 | 0.080 |
Why?
|
Cardiology | 1 | 2019 | 1723 | 0.070 |
Why?
|
Health Care Costs | 1 | 2021 | 3258 | 0.070 |
Why?
|
Pilot Projects | 1 | 2021 | 8555 | 0.070 |
Why?
|
Ambulatory Care | 2 | 2016 | 2781 | 0.070 |
Why?
|
Patient Admission | 1 | 2015 | 1386 | 0.070 |
Why?
|
Reproducibility of Results | 4 | 2018 | 20080 | 0.070 |
Why?
|
Comorbidity | 2 | 2019 | 10551 | 0.070 |
Why?
|
Anxiety Disorders | 1 | 2018 | 2714 | 0.070 |
Why?
|
Incidence | 7 | 2019 | 21392 | 0.070 |
Why?
|
Hospitalization | 5 | 2021 | 10790 | 0.070 |
Why?
|
Diuretics | 3 | 2016 | 613 | 0.070 |
Why?
|
Attitude to Health | 1 | 2015 | 2029 | 0.070 |
Why?
|
Reference Values | 1 | 2014 | 4925 | 0.070 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2013 | 1652 | 0.070 |
Why?
|
Endothelium, Vascular | 1 | 2018 | 4433 | 0.070 |
Why?
|
Recovery of Function | 1 | 2016 | 2985 | 0.070 |
Why?
|
Statistics as Topic | 1 | 2012 | 2362 | 0.060 |
Why?
|
Proto-Oncogene Proteins | 2 | 2015 | 4490 | 0.060 |
Why?
|
Motor Activity | 1 | 2015 | 2687 | 0.060 |
Why?
|
Contrast Media | 1 | 2019 | 5305 | 0.060 |
Why?
|
Cohort Studies | 6 | 2019 | 41335 | 0.060 |
Why?
|
Depressive Disorder | 1 | 2018 | 3726 | 0.060 |
Why?
|
Weight Loss | 1 | 2016 | 2686 | 0.060 |
Why?
|
Coronary Artery Bypass | 1 | 2014 | 2272 | 0.060 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2018 | 2290 | 0.060 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2015 | 2895 | 0.060 |
Why?
|
Artificial Intelligence | 1 | 2019 | 2557 | 0.060 |
Why?
|
Membrane Glycoproteins | 1 | 2014 | 3707 | 0.060 |
Why?
|
Acute-Phase Proteins | 2 | 2015 | 250 | 0.060 |
Why?
|
Kidney Diseases | 1 | 2014 | 2093 | 0.060 |
Why?
|
Pulmonary Artery | 1 | 2012 | 1921 | 0.060 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2017 | 3986 | 0.050 |
Why?
|
Coronary Vessels | 1 | 2014 | 3112 | 0.050 |
Why?
|
Antihypertensive Agents | 1 | 2012 | 2061 | 0.050 |
Why?
|
Sensitivity and Specificity | 4 | 2021 | 14660 | 0.050 |
Why?
|
Stents | 1 | 2014 | 3314 | 0.050 |
Why?
|
Ultrasonography | 2 | 2012 | 5961 | 0.050 |
Why?
|
Exercise | 1 | 2018 | 5787 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7475 | 0.050 |
Why?
|
Tomography, Optical Coherence | 1 | 2014 | 2884 | 0.050 |
Why?
|
Research Design | 1 | 2016 | 6180 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2016 | 8056 | 0.040 |
Why?
|
Standard of Care | 2 | 2016 | 552 | 0.040 |
Why?
|
Adult | 9 | 2020 | 219994 | 0.040 |
Why?
|
Massachusetts | 3 | 2018 | 8803 | 0.040 |
Why?
|
Survival Analysis | 3 | 2019 | 10182 | 0.040 |
Why?
|
Obesity | 2 | 2019 | 12922 | 0.040 |
Why?
|
Cross-Sectional Studies | 3 | 2018 | 25942 | 0.040 |
Why?
|
Kidney Failure, Chronic | 1 | 2012 | 2471 | 0.040 |
Why?
|
Pharmacological Phenomena | 1 | 2019 | 11 | 0.040 |
Why?
|
Physicians | 1 | 2017 | 4591 | 0.040 |
Why?
|
Area Under Curve | 2 | 2015 | 1636 | 0.040 |
Why?
|
Kidney | 1 | 2015 | 7064 | 0.040 |
Why?
|
Analysis of Variance | 2 | 2019 | 6238 | 0.040 |
Why?
|
Decision Trees | 1 | 2021 | 506 | 0.040 |
Why?
|
Odds Ratio | 3 | 2015 | 9716 | 0.040 |
Why?
|
Depression | 1 | 2017 | 8044 | 0.040 |
Why?
|
Principal Component Analysis | 1 | 2020 | 940 | 0.040 |
Why?
|
Inflammation | 1 | 2017 | 10756 | 0.040 |
Why?
|
Multivariate Analysis | 3 | 2016 | 12159 | 0.030 |
Why?
|
Prevalence | 3 | 2018 | 15687 | 0.030 |
Why?
|
Economics, Hospital | 1 | 2018 | 212 | 0.030 |
Why?
|
Mortality | 2 | 2018 | 2916 | 0.030 |
Why?
|
Cost Savings | 1 | 2021 | 920 | 0.030 |
Why?
|
Retrospective Studies | 6 | 2020 | 80372 | 0.030 |
Why?
|
Lipoproteins, HDL | 1 | 2019 | 667 | 0.030 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2016 | 306 | 0.030 |
Why?
|
Adiponectin | 1 | 2020 | 1115 | 0.030 |
Why?
|
Neointima | 1 | 2014 | 134 | 0.030 |
Why?
|
Endpoint Determination | 1 | 2016 | 597 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2019 | 2932 | 0.030 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2016 | 435 | 0.030 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2017 | 1126 | 0.030 |
Why?
|
Aging | 1 | 2012 | 8651 | 0.030 |
Why?
|
Solubility | 1 | 2015 | 1088 | 0.030 |
Why?
|
Creatinine | 1 | 2019 | 1903 | 0.030 |
Why?
|
Blood Chemical Analysis | 1 | 2015 | 437 | 0.030 |
Why?
|
Drug Combinations | 1 | 2019 | 2025 | 0.030 |
Why?
|
Animals | 2 | 2017 | 167963 | 0.030 |
Why?
|
International Classification of Diseases | 1 | 2018 | 894 | 0.030 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 2015 | 314 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2019 | 965 | 0.030 |
Why?
|
Cardiomyopathies | 1 | 2024 | 1952 | 0.030 |
Why?
|
Vasodilator Agents | 1 | 2016 | 978 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2019 | 2192 | 0.020 |
Why?
|
Digoxin | 1 | 2012 | 247 | 0.020 |
Why?
|
Drug Substitution | 1 | 2014 | 296 | 0.020 |
Why?
|
Receptors, Virus | 1 | 2014 | 639 | 0.020 |
Why?
|
Hyperplasia | 1 | 2014 | 1155 | 0.020 |
Why?
|
Interleukin-17 | 1 | 2017 | 910 | 0.020 |
Why?
|
Patient Care Planning | 1 | 2016 | 908 | 0.020 |
Why?
|
Echocardiography, Doppler | 1 | 2014 | 901 | 0.020 |
Why?
|
Galectins | 1 | 2013 | 282 | 0.020 |
Why?
|
Electric Impedance | 1 | 2014 | 755 | 0.020 |
Why?
|
Heart-Assist Devices | 1 | 2020 | 1291 | 0.020 |
Why?
|
Peroxidase | 1 | 2012 | 605 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2015 | 3465 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2020 | 3839 | 0.020 |
Why?
|
Quality Indicators, Health Care | 1 | 2018 | 1824 | 0.020 |
Why?
|
Young Adult | 1 | 2014 | 58741 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 2016 | 2417 | 0.020 |
Why?
|
Up-Regulation | 1 | 2016 | 4122 | 0.020 |
Why?
|
Cholesterol, LDL | 1 | 2016 | 2420 | 0.020 |
Why?
|
Linear Models | 1 | 2016 | 5877 | 0.020 |
Why?
|
Dietary Supplements | 1 | 2018 | 3392 | 0.020 |
Why?
|
Atrial Fibrillation | 1 | 2024 | 5209 | 0.020 |
Why?
|
Boston | 1 | 2018 | 9280 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2018 | 3598 | 0.020 |
Why?
|
Models, Biological | 1 | 2020 | 9467 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2018 | 4360 | 0.010 |
Why?
|
Genetic Testing | 1 | 2016 | 3531 | 0.010 |
Why?
|
Gene Expression | 1 | 2015 | 7588 | 0.010 |
Why?
|
Hemodynamics | 1 | 2012 | 4174 | 0.010 |
Why?
|
Registries | 1 | 2018 | 8469 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2018 | 14495 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2019 | 4775 | 0.010 |
Why?
|
Health Status | 1 | 2012 | 4081 | 0.010 |
Why?
|
Intensive Care Units | 1 | 2012 | 3736 | 0.010 |
Why?
|
Phenotype | 1 | 2015 | 16546 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2016 | 15789 | 0.010 |
Why?
|